Learn how to manage patient transitions to authorized generics to reduce costs while maintaining the therapeutic consistency of brand-name medications.
Learn how to manage patient transitions to authorized generics to reduce costs while maintaining the therapeutic consistency of brand-name medications.
Biosimilars are the biologic equivalent of generic drugs - highly similar, proven safe, and significantly cheaper. Learn how they compare to authorized generics, why adoption is slow, and what’s changing in 2026.